- Home
- LYEL vs CLBR Comparison
LYEL vs CLBR Comparison
Compare LYEL & CLBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LYEL
- CLBR
- Stock Information
- Founded
- LYEL 2018
- CLBR 2023
- Country
- LYEL United States
- CLBR United States
- Employees
- LYEL N/A
- CLBR N/A
- Industry
- LYEL Biotechnology: Pharmaceutical Preparations
- CLBR
- Sector
- LYEL Health Care
- CLBR
- Exchange
- LYEL Nasdaq
- CLBR Nasdaq
- Market Cap
- LYEL 263.9M
- CLBR 240.1M
- IPO Year
- LYEL 2021
- CLBR 2023
- Fundamental
- Price
- LYEL $0.62
- CLBR $11.85
- Analyst Decision
- LYEL Sell
- CLBR
- Analyst Count
- LYEL 2
- CLBR 0
- Target Price
- LYEL $1.00
- CLBR N/A
- AVG Volume (30 Days)
- LYEL 1.5M
- CLBR 306.9K
- Earning Date
- LYEL 11-07-2024
- CLBR 01-01-0001
- Dividend Yield
- LYEL N/A
- CLBR N/A
- EPS Growth
- LYEL N/A
- CLBR N/A
- EPS
- LYEL N/A
- CLBR N/A
- Revenue
- LYEL $63,000.00
- CLBR N/A
- Revenue This Year
- LYEL N/A
- CLBR N/A
- Revenue Next Year
- LYEL N/A
- CLBR N/A
- P/E Ratio
- LYEL N/A
- CLBR $151.88
- Revenue Growth
- LYEL N/A
- CLBR N/A
- 52 Week Low
- LYEL $0.58
- CLBR $9.16
- 52 Week High
- LYEL $3.26
- CLBR $12.28
- Technical
- Relative Strength Index (RSI)
- LYEL 27.76
- CLBR 63.16
- Support Level
- LYEL $0.58
- CLBR $11.40
- Resistance Level
- LYEL $0.95
- CLBR $11.96
- Average True Range (ATR)
- LYEL 0.07
- CLBR 0.32
- MACD
- LYEL -0.02
- CLBR 0.00
- Stochastic Oscillator
- LYEL 6.48
- CLBR 55.56
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.
About CLBR Colombier Acquisition Corp. II
Colombier Acquisition Corp II is a blank check company.